Melanin-concentrating hormone activates signaling pathways in 3T3-L1 adipocytes

Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E584-92. doi: 10.1152/ajpendo.00161.2002.

Abstract

Energy homeostasis is regulated by peripheral signals, such as leptin, and by several orexigenic and anorectic neuropeptides. Recently, we reported that the orexigenic neuropeptide melanin-concentrating hormone (MCH) stimulates leptin production by rat adipocytes and that the MCH receptor (MCH-R1) is present on these cells. Here, we show that MCH-R1 is present on murine 3T3-L1 adipocytes. Treatment of 3T3-L1 adipocytes with 1 micromolar MCH for up to 2 h acutely downregulated MCH-R1, indicating a mechanism of ligand-induced receptor downregulation. Potential signaling pathways mediating MCH-R1 action in adipocytes were investigated. Treatment of 3T3-L1 adipocytes with 1 micromolar MCH rapidly induced a threefold and a fivefold increase in p44/42 MAPK and pp70 S6 kinase activities, respectively. In addition, 3T3-L1 adipocytes transiently transfected with a murine leptin-luciferase promoter construct showed a fourfold and a sixfold increase in leptin promoter-reporter gene expression at 1 h and 4 h, respectively, in response to MCH. Activity decreased to basal levels at 8 h. Furthermore, MCH-stimulated leptin promoter-driven luciferase activity was diminished in the presence of the MAP/ERK kinase inhibitor PD-98059 and in the presence of rapamycin, an inhibitor of pp70 S6 kinase activation. These results provide further evidence for a functional MCH signaling pathway in adipocytes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3T3 Cells
  • Adipocytes / drug effects*
  • Adipocytes / physiology*
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Down-Regulation
  • Ethanolamines / pharmacology
  • Hypothalamic Hormones / pharmacology*
  • Insulin / pharmacology
  • Leptin / genetics
  • Leptin / pharmacology
  • Luciferases / metabolism
  • Melanins / pharmacology*
  • Mice
  • Pituitary Hormones / pharmacology*
  • Promoter Regions, Genetic / physiology
  • Receptors, Pituitary Hormone / metabolism
  • Signal Transduction / drug effects*

Substances

  • Adrenergic beta-Agonists
  • Ethanolamines
  • Hypothalamic Hormones
  • Insulin
  • Leptin
  • Melanins
  • Pituitary Hormones
  • Receptors, Pituitary Hormone
  • melanin-concentrating hormone receptor
  • BRL 37344
  • melanin-concentrating hormone
  • Luciferases